C-type natriuretic peptide prevents activation of perivascular mast cells and inflammation in the postischemic microvasculature by unknown
MEETING ABSTRACT Open Access
C-type natriuretic peptide prevents activation of
perivascular mast cells and inflammation in the
postischemic microvasculature
Wen Chen1*, Katharina Völker1, Birgit Gaßner1, Franziska Werner1, Anja Rabenhorst2, Karin Hartmann2,
Michaela Kuhn1
From 7th International Conference on cGMP Generators, Effectors and Therapeutic Implications
Trier, Germany. 19-21 June 2015
Background
Atrial- and C-type- natriuretic peptides (ANP, CNP) are
both vasodilatatory hormones which are mainly secreted
from cardiac atria and vascular endothelium, respec-
tively. Both peptides activate cyclic GMP (cGMP) for-
mation by binding to their specific receptors: the
particulate guanylyl cyclases A (GC-A) and B (GC-B).
Cyclic GMP via cGMP-dependent protein kinase I
(cGKI) was shown to inhibit mast cell (MC) degranula-
tion [1]. During postischemic reperfusion, the activation
of MC is detrimental [2]. Due to pleiotropic effects,
cytokines released from MC cause tissue damage and
vascular leakage. It is unclear whether and how ANP
and/or CNP regulate the activity of MC and, thereby,
influence ischemia-reperfusion-induced disruption of the
microvascular barrier.
Methods and results
Intravital microscopy was used to visualize the microcircu-
lation within the cremaster muscle of anesthetized mice,
and Fluorescein isothiocyanate (FITC)-Dextran was
injected intravenously to quantify the microvascular leak-
age [3,4]. Cremaster blood flow was temporally blocked
with an arterial clamp to provoke 30 min of tissue ische-
mia. During the following 30 min of postischemic reperfu-
sion, the vascular leakage was measured by the ratio of the
fluorescent (FITC-Dextran) intensity (RFI) between the
adjacent interstitial space and the intravascular lumen.
Subsequently resident perivascular degranulated MCs
were stained by superfusing Ruthenium Red solution and
thereafter counted (number per field).
In wildtype mice, ischemia-reperfusion (compared to
sham operated cremaster muscles) provoked marked MC
degranulation and robust vascular leakage of FITC-
Dextran (as indicated by higher RFI). Local CNP superfu-
sion during reperfusion significantly reduced the amount
of degranulated MCs and concomitantly vascular leakage.
These effects were mimicked by the membrane-perme-
able cGKI activator 8-Br-cGMP. The protective effects of
8-Br-cGMP were endothelium-independent, since they
were preserved in mice with conditional, endothelial
deletion of cGKI. Quantitative real-time RT-PCR
revealed local CNP-mRNA expression in the m. cremas-
ter, which was not altered by acute ischemia. In contrast
to CNP, ANP superfusion did not significantly alter the
amount of degranulated MCs, but still effectively reduced
FITC-Dextran leakage resulted from ischemia-reperfusion.
Accordingly, in vitro, in cultured human MCs (HMC-1.1,
originally developed by Dr. Butterfield and a gift from
Dr. Drube) and primary cultured murine bone marrow
MC, CNP, but not ANP, induced a marked increase in
intracellular cGMP levels and enhanced the phosphoryla-
tion of the cytoskeleton-associated vasoactive stimulated
phosphoprotein (VASP) at Ser237.
Conclusions
Our study shows divergent effects of NPs in the postis-
chemic microcirculation. CNP inhibited the ischemic
activation of resident, perivascular MCs and conse-
quently the associated microvascular leakage, possibly via
MC specific cGMP/cGKI signaling. At difference, ANP
had no effect on MCs but still attenuated the postis-
chemic vascular barrier disruption via direct effects on
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vascular cell-specific effects and signaling pathways of
both NPs and possible clinical implications.
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